Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EVINACUMAB-DGNB for Hypercholesterolaemia: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 8 adverse event reports in the FDA FAERS database where EVINACUMAB-DGNB was used for Hypercholesterolaemia.

Most Reported Side Effects for EVINACUMAB-DGNB

Side Effect Reports % Deaths Hosp.
Nausea 14 15.2% 0 1
Fatigue 12 13.0% 0 2
Pain 9 9.8% 0 1
Hepatic steatosis 7 7.6% 0 0
Diarrhoea 6 6.5% 0 0
Dizziness 6 6.5% 0 0
Drug ineffective 6 6.5% 0 1
International normalised ratio increased 6 6.5% 0 0
Product dose omission issue 6 6.5% 0 0
Death 5 5.4% 5 0
Headache 5 5.4% 0 0

Other Indications for EVINACUMAB-DGNB

Type iia hyperlipidaemia (50) Product used for unknown indication (33)

Other Drugs Used for Hypercholesterolaemia

EVOLOCUMAB (23,505) ATORVASTATIN (5,615) ALIROCUMAB (4,924) SIMVASTATIN (3,010) ROSUVASTATIN (2,690) EZETIMIBE (1,589) PRAVASTATIN (764) INCLISIRAN (486) FENOFIBRATE (286) FLUVASTATIN (264)

Related Pages

EVINACUMAB-DGNB Full Profile All Hypercholesterolaemia Drugs EVINACUMAB-DGNB Demographics EVINACUMAB-DGNB Timeline